Home » Topics » BioWorld Science

BioWorld Science
RSS

EMA committee recommends approval of Prolia for bone loss associated with glucocorticoid therapy

April 30, 2018

Advantagene and BMS enter clinical trial collaboration

April 30, 2018

DisperSol initiates phase II trials of DST-0509 in iron overload disorder

April 30, 2018

Tagrisso receives positive opinion in Europe for first-line EGFR-mutated NSCLC

April 30, 2018

INSYS initiates phase II study of cannabidiol oral solution for treatment of Prader-Willi syndrome

April 30, 2018

EMA's CHMP adopts positive opinion for Dzuveo

April 30, 2018

Biktarvy granted positive opinion in Europe

April 30, 2018

ITI-214, a potential candidate for the treatment of Parkinson's disease

April 30, 2018

Janssen monoclonal antibody JNJ-64164711 depletes Tregs in tumor samples

April 30, 2018

REGN-4659 demonstrates antitumor activity in vivo

April 30, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...